about
Buprenorphine for neuropathic pain in adultsHydromorphone for neuropathic pain in adultsBuprenorphine for neuropathic pain in adultsFentanyl for neuropathic pain in adultsInterventions for the reduction of prescribed opioid use in chronic non-cancer painInterventions for the reduction of prescribed opioid use in chronic non-cancer painGuidance on the management of pain in older people.Changes in trends and pattern of strong opioid prescribing in primary careAcupuncture or low frequency infrared treatment for low back pain in Chinese patients: a discrete choice experimentEvidence-based clinical practice guidelines on the management of pain in older people: executive summary.Systematic Review of Economic Evaluations In Multidisciplinary Pain Management Services for Managing People With Fibromyalgia or Chronic Widespread Pain.Guest Editorial: British Journal of Pain: the story so far.The Feasibility of Applying Definitions of Persistent Opioid Utilisation to Quantify The Persistency of Tramadol Users.Change of datasheet for ketorolac.The pupillary effects of intravenous morphine, codeine, and tramadol in volunteers.A 15-year overview of increasing tramadol utilisation and associated mortality and the impact of tramadol classification in the United Kingdom.Evidence-based clinical practice guidelines on management of pain in older people.Providing effective pain managementOpioids, opioids and more opioidsSecondary care specialist visits made by children and young people prescribed antidepressants in primary care: a descriptive study using the QResearch databaseParticulate steroids in axial spinal blockade and the increasing role of patient consent: Les grains de sable dans l'engrenage
P50
Q24186924-B15B7F38-BAA9-486A-BDE4-1948AD1C092CQ24187550-3FFB1808-3A69-4FFF-AB59-964C133190C6Q24187555-FC6F352E-7543-40BF-B6A8-5E57015D6D44Q24187562-ECF2C5B7-F7EB-4B61-8701-CDCBB3F7F0B5Q24198272-F4411FB2-35A9-4351-A2AA-56B384692A52Q24202027-C7F833CC-CE32-41E6-9BBC-F2459DACCFB9Q34328425-7608ACFC-12DB-4948-BC40-E64FE4CEA687Q34548856-64E2E97B-C435-44B6-9CA7-C759E36824FAQ35644540-47569AA3-26E4-4CEC-B4E9-78DD055461A3Q36110541-3025BA5E-9511-4E73-90C1-19B3C1156DCAQ38624463-CD46357F-687D-4621-91C9-10703C5679E4Q40376305-F6FC1486-70B7-445B-829F-91C22B001654Q44333354-AD39DB22-7FBA-4053-9D51-AA15DC5D7C9CQ44776827-A066E017-14F7-415A-BA58-240559A3E3AEQ44998546-BE63D2C4-4727-479C-A797-EE9BEE1EC117Q47928794-8D322CD1-7334-446F-8104-4ACD72B06A53Q48097193-182B9530-E9B0-41D7-BB14-8F7144CE0336Q81948819-79A2507F-CB01-4BA3-A91B-C297128CD0C8Q91908605-8896EF25-1655-4B62-9C8A-A850A823A42BQ94460576-893E3BD9-8C9F-4199-9B34-BB0EDD3605A2Q96345848-2F78FE17-9E17-4D4F-848A-38CF7363D725
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Roger Knaggs
@ast
Roger Knaggs
@en
Roger Knaggs
@es
Roger Knaggs
@nl
Roger Knaggs
@sl
type
label
Roger Knaggs
@ast
Roger Knaggs
@en
Roger Knaggs
@es
Roger Knaggs
@nl
Roger Knaggs
@sl
prefLabel
Roger Knaggs
@ast
Roger Knaggs
@en
Roger Knaggs
@es
Roger Knaggs
@nl
Roger Knaggs
@sl
P106
P1153
6602949940
P21
P31
P496
0000-0003-1646-8321